artificial intelligence Archives - Page 11 of 11

Perimeter Medical Imaging to go public in Toronto

Perimeter Medical Imaging — creator of AI-based medical imaging tools for cancer surgery — plans to go public on the TSX Venture Exchange in Toronto on the week of June 29.

The Toronto- and Dallas-based company is going public at the same time that it enters the commercial stage for its proprietary, FDA-cleared OCT imaging platform. Perimeter Medical Imaging officials say their imaging platform is able to provide real-time, microscopic-scale imaging information during surgery.

“Taking Perimeter public at this stage of the company’s life cycle will be instrumental in the success of the organization. Our technology should be in the hands of as many physicians as possible, and being a public company provides us access to the capital needed to scale in support of our growth,” Perimeter CFO Jeremy Sobotta said in a news release.

Perimeter Medical Imaging’s ticker will be PINK, an allusion to the pink breast cancer allusion ribbons. The company…

GE Healthcare launches chest X-ray AI to better spot COVID-19

Officials at GE Healthcare (NYSE:GE) think the company’s new Thoracic Care Suite — a collection of eight AI algorithms from Lunit Insight CXR — could help clinicians in the fight against COVID-19.

The AI suite, launched today, quickly analyzes chest X-ray findings and flags abnormalities for radiologist review, according to GE. It can spot potential pneumonia — a symptom of COVID-19. It can also highlight tuberculosis, lung nodules, and other radiological findings.

Get the full story on our sister site Medical Design & Outsourcing.

Accuray launches CyberKnife S7 system

CyberKnife S7 system (Image from Accuray)

Accuray (NSDQ:ARAY) announced today that it launched its CyberKnife S7 system for stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT).

Using real-time artificial intelligence-driven motion tracking and synchronization, CyberKnife S7 offers treatments for SRS and SBRT in as little as 15 minutes, according to a news release.

The system’s AI adapts radiation delivery to patient and/or tumor movement throughout the course of treatment while offering more positions from which radiation beams can be delivered, giving physicians the ability to maximize radiation doses to the tumor and minimize doses to the surrounding healthy tissues, according to a news release.

Sunnyvale, Calif.-based Accuray touts its next-generation system from the CyberKnife platform as capable of treating cancerous and benign tumors throughout the body, a…

Zebra Medical Vision wins FDA clearance for AI to predict osteoporosis

Zebra Medical Vision announced today that it received its fifth FDA 510(k) clearance for its Vertebral Compression Fractures (VCF) product.

The Kibbutz Shefayim, Israel-based company’s latest artificial intelligence-based product automatically identifies findings suggestive of compression fractures, which enables clinicians to place patients that are at risk of osteoporosis in treatment pathways that can prevent potentially life-changing fractures.

VCF expands Zebra’s AI1 bundle of FDA-cleared AI products, which now has a fourth U.S. patent in its bone health series, according to a news release. Zebra touts itself as the first AI startup in medical imaging to receive FDA clearance for a population health solution.

“Identifying patients at risk for osteoporosis has a significant impact on patients’ well-being, as 70 percent of vertebral compression fractures are under detected globally,” Zebra CEO Ohad Arazi said in the news release. “Th…

Could AI predict COVID-19 without testing?

Researchers in England and Massachusetts have developed an artificial intelligence diagnostic that can predict the likelihood of someone having COVID-19 based on symptoms.

King’s College London, Massachusetts General Hospital and health science company Zoe have developed an AI model that uses data from the COVID Symptom Study app to help predict COVID-19 infection. It compares symptoms and the results of traditional COVID tests to help populations that have limited access to testing.

According to the researchers, more than 3.3 million people around the world have downloaded the app and are reporting daily health status.

The researchers have analyzed data from 2.5 million people in the U.S. and the U.K who have regularly been logging their health in the app. About one-third of the people logged COVID-19 related symptoms. Of the one-third, 18,374 have had a coronavirus test and 7,178 tested positive.

Symptoms associated with COVID-19 were anal…